The lower methylation level of cg08889930, an enhancer of MCM2, and higher expression of MCM2 mRNA predicted shorter overall survival (OS) for HCC patients in The Cancer Genome Atlas (TCGA) cohort (Tang et al. 2022). The gene discussed is MCM2; the disease is hepatocellular carcinoma.